Klow 80MG

Volume Pricing

Research Overview

KLOW is a research blend combining KPV, GHK-Cu, BPC-157, and TB-500 in a single vial. It unites an anti-inflammatory tripeptide, a copper skin peptide, and two tissue-repair peptides for multi-pathway research.

Each component is independently referenced: KPV in inflammation and gut endpoints, GHK-Cu in skin and collagen, and BPC-157 with TB-500 in tissue repair — combined here for broad skin, gut, and recovery research models.

Research Focus

Mechanism (Research Context)

KLOW is studied as a combined system in which KPV modulates inflammatory signaling, GHK-Cu influences matrix and collagen pathways, and BPC-157 with TB-500 act on angiogenic and actin-regulation pathways, together spanning skin, gut, and recovery endpoints in research models.

Intended Use

This compound is strictly intended for in vitro laboratory research. It is not for use in humans or animals. Not to be used in foods, drugs, or medical diagnostics.

Legal Disclaimer

This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Usage is restricted to certified laboratories and qualified research professionals.

Terms of Sale

All sales by Codex Research are final. Buyers must be qualified professionals and assume full responsibility for safe handling and regulatory compliance. Every batch is independently verified by accredited third-party laboratories. Batch-specific Certificates of Analysis are available on our COAs page.